Trial intelligence / Profile preview

Phase II study of AYP-101 subcutaneous injection for reduction of submental fat

KCT0004034Phase 2Recruiting

Sponsor
AMIpharm
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of polyene phosphatidylcholine in submental fat, sponsored by AMIpharm. Started Jul 2019; status: recruiting.

02

Drugs

polyene phosphatidylcholine
03

Conditions

submental fat

Beyond the preview

Go deeper on KCT0004034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call